National and Kapodistrian University of Athens
Οστικός μεταβολισμός σε διαταραχές της θυρεοειδικής λειτουργίας
Abstract
dc:descriptionThe thyroidopathies associated with abnormal thyroid hormone levels (either high or low) have a determinant impact on bone metabolism. The therapeutic correction of such situations seems to restore normal bone function. The aim of this thesis was to evaluate the medium-term correspondence of the skeletal system after therapeutic restoration of normal thyroid levels in hyper and hypothyroid patients. For this purpose, we monitored the trimestrial change of the contemporary bone markers and the semestrial change of the bone density in 52 women with thyroidopathy, for a total period of two years. These patients were distributed in 4 subgroups (A: 19 patients at the age of 35.9±13.8 years with clinical hyperthyroidism, B: 6 patients, 42.3±11.3 years, with endogenous subclinical hyperthyroidism, C: 14 patients, 44.9±11 years, with clinical hypothyroidism and D: 13 patients, 48.2±10.3 years, with subclinical hypothyroidism). All groups, with the exception of group B, had some kind of therapeutic intervention to achieve normal thyroid function. The objective of the therapeutic intervention was achieved in all subgroups by the first trimester of follow-up. In clinically hyperthyroid patients, the reduction of free Τ4 was accompanied by reduction in the corrected calcium (Ca (corr) p<0.01), increase of parathyroid hormone (PTH p<0.01), continuous reduction of osteoclastic markers (serum ΝΤΧ p<0.01, urine ΝΤΧ p<0.05) and increase in bone specific alkaline phosphatase (bsALP p<0.05) by the first trimester of follow-up. Bone Gla Protein began to decrease constantly 6 months after treatment initiation and thereforth (BGP p<0.05). Calcium remained in lower levels throughout the study, while PTH and bsALP began to decrease after a half-year period. In the same interval, 25 hydroxyvitamine D decreased in an opposite manner (p<0.01) in relation to PTH, and the active metabolite, 1,25 dihydroxyvitamine D, increased (p<0.05). In our study group of hyperthyroid patients a change in calcitonin, insulin growth factor 1 (IGF -1), tumor necrosis factor a (TNFa) and leptin was not observed, while interleukin 6 (IL -6) decreased in a subgroup of patients with high serum levels at baseline. These changes were followed by an increase in the bone mineral density of the femur neck by the first year of follow-up (p < 0.01). No change was observed in subgroup B. Subgroup C, as well as subgroup D, presented similar changes of markers during the study period. PTH did not present statistically important fluctuations, while the osteoclastic markers showed a progressive increase, statistically significant after 18 months of intervention (p<0.01).
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Αλουμανής, Κυριάκος
- Aloumanis, Kyriakos
Subjects
dc:subject × 18- Οστικός μεταβολισμός
- Θυροειδής αδένας
- Υπερθυρεοειδισμός
- Υποθυρεοειδισμός
- Οστεοπόρωση
- Οστικός μεταβολισμός, Δείκτες
- Οστική πυκνότητα
- Bone metabolism
- Thyroid
- Hyperthyroidism
- Hypothyroidism
- Osteoporosis
- Bone markers
- Bone density
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/5812